Six-year follow-up of a child with familial chylomicronemia syndrome: disease course and effectiveness of gemfibrozil treatment --case report and literature review
4
조회
0
다운로드
0
인용
0
참고문헌
키워드
초록
Familial chylomicronemia syndrome (FCS) is a rare autosomal recessive disease affecting lipoprotein metabolism. FCS is estimated to occur in 1 in 1–2 million individuals and can be diagnosed at any age, equally affecting all genders, races, and ethnicities. The condition is characterized by hypertriglyceridemia, which may predispose patients to acute pancreatitis. In this report, we present the case of a now 6-year-old girl with FCS on gemfibrozil and dietary restrictions. The patient initially presented at 40 days of age with vomiting. Serum samples revealed lipemia, with markedly elevated triglyceride levels. The patient was diagnosed with FCS, confirmed by genetic testing showing the homozygous variant c.833C>T(p,Ser278Phe) for the LPL gene. Despite being on a low-fat diet with medium chain triglyceride (MCT) based milk formulas, the patient developed acute pancreatitis 2 months later with continued elevated triglyceride levels. She was placed on gemfibrozil and fat-soluble vitamins at 2 months of age, with marked improvements subsequently noted. Currently, the patient is doing well, with normal growth parameters and no other episodes of acute pancreatitis. Her triglyceride levels have been maintained within normal levels. FCS is a rare, inherited lipid disorder that often goes underdiagnosed and unmanaged. It is worth considering the fibric acid derivative (gemfibrozil) to be one of the lines of management early on after diagnosis.
Abstract
Familial chylomicronemia syndrome (FCS) is a rare autosomal recessive disease affecting lipoprotein metabolism. FCS is estimated to occur in 1 in 1–2 million individuals and can be diagnosed at any age, equally affecting all genders, races, and ethnicities. The condition is characterized by hypertriglyceridemia, which may predispose patients to acute pancreatitis. In this report, we present the case of a now 6-year-old girl with FCS on gemfibrozil and dietary restrictions. The patient initially presented at 40 days of age with vomiting. Serum samples revealed lipemia, with markedly elevated triglyceride levels. The patient was diagnosed with FCS, confirmed by genetic testing showing the homozygous variant c.833C>T(p,Ser278Phe) for the LPL gene. Despite being on a low-fat diet with medium chain triglyceride (MCT) based milk formulas, the patient developed acute pancreatitis 2 months later with continued elevated triglyceride levels. She was placed on gemfibrozil and fat-soluble vitamins at 2 months of age, with marked improvements subsequently noted. Currently, the patient is doing well, with normal growth parameters and no other episodes of acute pancreatitis. Her triglyceride levels have been maintained within normal levels. FCS is a rare, inherited lipid disorder that often goes underdiagnosed and unmanaged. It is worth considering the fibric acid derivative (gemfibrozil) to be one of the lines of management early on after diagnosis.
참고문헌 (14)
- Dai S, "Non-high-density lipoprotein cholesterol : distribution and prevalence of high serum levels in children and adolescents : United States National Health and Nutrition Examination Surveys, 2005-2010", J Pediatr, 164, pp.247~253 (2014)
- Susheela AT, "Familial chylomicronemia syndrome : a case report", J Med Case Rep, 15, pp.5~ (2021)
- Burnett JR, "GeneReviews®" (1999), University of Washington
- Pouwels ED, "Severe hypertriglyceridaemia as a result of familial chylomicronaemia : the Cape Town experience", S Afr Med J, 98, pp.105~108 (2008)
- "Familial hyperchylomicronemia syndrome" (2024)[URL]
- Baass A, "Familial chylomicronemia syndrome : an under-recognized cause of severe hypertriglyceridaemia", J Intern Med, 287, pp.340~348 (2020)
- Chaurasiya OS, "An infant with milky blood : an unusual but treatable case of familial hyperlipidemia", Indian J Clin Biochem, 28, pp.206~209 (2013)
- Kuthiroly S, "Lipoprotein lipase deficiency", Indian J Pediatr, 88, pp.147~153 (2021)
- Wu YQ, "Rare novel LPL mutations are associated with neonatal onset lipoprotein lipase(LPL)deficiency in two cases", BMC Pediatr, 21, pp.414~ (2021)
- Bijvoet SM, "Homozygosity for a mutation in the lipoprotein lipase gene(Gly139-->Ser)causes chylomicronaemia in a boy of Spanish descent", Hum Genet, 93, pp.339~343 (1994)
- Stroes E, "Diagnostic algorithm for familial chylomicronemia syndrome", Atheroscler Suppl (2017)[DOI]
- Al Azkawi H, "Two siblings with familial chylomicronemia syndrome : disease course and effectiveness of early treatment", Case Rep Med, 2010, pp.807434~ (2010)
- Yuan G, "Hypertriglyceridemia : its etiology, effects and treatment", CMAJ, 176, pp.1113~1120 (2007)
- Shah MH, "Neonatal hyperlipidemia with pancreatitis : novel gene mutation of lipoprotein lipase", J Postgrad Med, 64, pp.247~249 (2018)